An E6 Oncoprotien Based Diagnostic Test for Cervical Pre-Cancer and Cancer

This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.

Author(s): Berard-Bergery M, Bisht A, Ho M, et al

Corporate author(s): PATH, Arbor Vita Corporation, Johns Hopkins Bloomberg School of Public Health

Publication date: July 2010

Available materials

English

An E6 Oncoprotein Based Diagnostic Test for Cervical Pre-Cancer and Cancer (poster)

363 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA